Life Science Company News

Reset
Results 1 - 20 out of 500 displayed.
1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

Declaration of shares and voting rights April 30, 2024 - VALNEVA SE

Read more ››
By: GlobeNewswire - 06 May 2024
Related companies:  Valneva SE

Cellectis Announces Completion of the Additional Equity Investment by AstraZeneca

Read more ››
By: GlobeNewswire - 06 May 2024
Related companies:  Cellectis Inc.

Health Canada Approves Nexstim NBS 6 System for Treatment of MDD

Read more ››
By: GlobeNewswire - 06 May 2024
Related companies:  Nexstim Plc

Curium Announces First Commercial Doses in Germany of PYLCLARI® – An Innovative 18F-PSMA PET Tracer Indicated in Patients With Prostate Cancer

Read more ››
By: GlobeNewswire - 06 May 2024
Related companies:  Curium Pharma

Virbac : Declaration of the number of shares and voting rights

Read more ››
By: GlobeNewswire - 06 May 2024
Related companies:  Virbac SA

Orion Corporation: Managers’ transactions – Kari Jussi Aho

Read more ››
By: GlobeNewswire - 06 May 2024
Related companies:  Orion Oyj

Orion Corporation: Managers’ transactions – Ari Lehtoranta

Read more ››
By: GlobeNewswire - 06 May 2024
Related companies:  Orion Oyj

Orion Corporation: Managers’ transactions – Eija Ronkainen

Read more ››
By: GlobeNewswire - 06 May 2024
Related companies:  Orion Oyj

Orion Corporation: Managers’ transactions – Veli-Matti Mattila

Read more ››
By: GlobeNewswire - 06 May 2024
Related companies:  Orion Oyj

Orion Corporation: Managers’ transactions – Henrik Stenqvist

Read more ››
By: GlobeNewswire - 06 May 2024
Related companies:  Orion Oyj

Orion Corporation: Managers’ transactions – Maziar Mike Doustdar

Read more ››
By: GlobeNewswire - 06 May 2024
Related companies:  Orion Oyj

Orion Corporation: Managers’ transactions – Hilpi Rautelin

Read more ››
By: GlobeNewswire - 06 May 2024
Related companies:  Orion Oyj

Boehringer Ingelheim shares positive results from the first study worldwide in diabetic macular ischemia

Read more ››
By: GlobeNewswire - 06 May 2024

Orion Corporation: Managers’ transactions – Karen Lykke Sørensen

Read more ››
By: GlobeNewswire - 06 May 2024
Related companies:  Orion Oyj

Integra LifeSciences Reports First Quarter 2024 Financial Results

Read more ››
By: GlobeNewswire - 06 May 2024
Related companies:  Integra LifeSciences

ADC Therapeutics Announces Initial Data from Investigator-Initiated Phase 2 Clinical Trial of ZYNLONTA® in Patients with Relapsed/Refractory Marginal Zone Lymphoma

Read more ››
By: GlobeNewswire - 06 May 2024
Related companies:  ADC Therapeutics SA

Brains Bioceutical Announces the Addition of Industry Veteran John Boshart to its Animal Health Division

Read more ››
By: GlobeNewswire - 06 May 2024
Related companies:  Brains Bioceutical Corp.

AsclepiX Therapeutics Completes Enrollment in DISCOVER Trial for Neovascular Age-Related Macular Degeneration (nAMD)

Read more ››
By: GlobeNewswire - 06 May 2024
Related companies:  Asclepix Therapeutics, Inc.

ADC Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Updates

Read more ››
By: GlobeNewswire - 06 May 2024
Related companies:  ADC Therapeutics SA

Genenta Welcomes New Directors John L. Cantello, Lauren H. Chung, Armon R. Sharei, and Todd Wider

Read more ››
By: GlobeNewswire - 06 May 2024
Related companies:  Genenta Science s.r.l.
Results 1 - 20 out of 500 displayed.
1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

Enhance your business development with Biotechgate
Try for free »